FindTrial
Sign In

To compare and evaluate ozonoid olive oil, MTA and Calcium Hydroxide as an Indirect Pulp Capping Agent in Permanent Molars

Evaluation of Ozonoid Olive Oil as an Indirect Pulp Capping Agent in Permanent Molars: A Randomised Clinical Trial - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061819
Enrollment
60
Registered
2024-01-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K029- Dental caries, unspecified Health Condition 2: K029- Dental caries, unspecified

Interventions

Intervention1: Clinical and Radiographic Evaluation: 6 months Control Intervention1: MTA, Ozonoid Olive Oil, Calcium Hydroxide(Dycal): 6 months

Sponsors

Dr Hemal Bjaaj
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Molars having occlusal or proximal deep carious lesion. Teeth with response suggestive of normal pulp or reversible pulpitis detected through electric pulp testing or thermal stimulation and radiographically teeth having a Periapical Index score of 1 was included

Exclusion criteria

Exclusion criteria: Patients with systemic diseases Teeth with pulp exposure, spontaneous unprovoked pain, sinus opening, periodontium inflammation, mobility, cracked tooth, furcal radiolucency, internal or external resorption, and periapical lesion

Design outcomes

Primary

MeasureTime frame
considering dropout rates of 10 percent sample size will be 60 subjects and outcome is to compare and evaluate three different materials used for indirect pulp capping in permanent molars at 3 and 6 months of interval.Timepoint: 3months and 6 months—

Secondary

MeasureTime frame
clinical and radiographic evaluationTimepoint: 3months and 6 months—

Countries

India

Contacts

Public ContactDr Rashmi Nair

Chhattisgarh Dental College and Research Institute, Sundra, Rajnandgaon 491441

bajaj.hemal@gmail.com8349405020

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026